166 related articles for article (PubMed ID: 30414956)
1. Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals.
Krimphove MJ; Fletcher SA; Cole AP; Berg S; Sun M; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Kluth LA; Weissman JS; Trinh QD
J Urol; 2019 Apr; 201(4):735-741. PubMed ID: 30414956
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
Fletcher SA; Gild P; Cole AP; Vetterlein MW; Kibel AS; Choueiri TK; Sonpavde GP; Preston MA; Pucheril D; Menon M; Sun M; Lipsitz SR; Trinh QD
Urol Oncol; 2018 May; 36(5):238.e7-238.e17. PubMed ID: 29454591
[TBL] [Abstract][Full Text] [Related]
3. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.
Nguyen DD; Labban M; Briggs L; Wallis CJD; Cole AP; Lipsitz SR; Iyer HS; Rebbeck TR; Weissman JS; Choueiri TK; Trinh QD
Urol Oncol; 2023 May; 41(5):252.e9-252.e17. PubMed ID: 36759298
[TBL] [Abstract][Full Text] [Related]
4. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
[TBL] [Abstract][Full Text] [Related]
5. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.
Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
[TBL] [Abstract][Full Text] [Related]
6. Racial Disparities in Treatment for Rectal Cancer at Minority-Serving Hospitals.
Lu PW; Scully RE; Fields AC; Welten VM; Lipsitz SR; Trinh QD; Haider A; Weissman JS; Freund KM; Melnitchouk N
J Gastrointest Surg; 2021 Jul; 25(7):1847-1856. PubMed ID: 32725520
[TBL] [Abstract][Full Text] [Related]
7. Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort.
Wang EH; Yu JB; Abouassally R; Meropol NJ; Cooper G; Shah ND; Williams SB; Gonzalez C; Smaldone MC; Kutikov A; Zhu H; Kim SP
Urology; 2016 Sep; 95():88-94. PubMed ID: 27318264
[TBL] [Abstract][Full Text] [Related]
8. Racial and ethnic disparities within and between hospitals for inpatient quality of care: an examination of patient-level Hospital Quality Alliance measures.
Hasnain-Wynia R; Kang R; Landrum MB; Vogeli C; Baker DW; Weissman JS
J Health Care Poor Underserved; 2010 May; 21(2):629-48. PubMed ID: 20453362
[TBL] [Abstract][Full Text] [Related]
9. Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.
Ong WL; Foroudi F; Evans S; Millar J
BJU Int; 2017 Nov; 120 Suppl 3():35-42. PubMed ID: 28749017
[TBL] [Abstract][Full Text] [Related]
10. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
[TBL] [Abstract][Full Text] [Related]
11. Disparities in NCCN Guideline Compliant Care for Resectable Cholangiocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals.
Tsilimigras DI; Dalmacy D; Hyer JM; Diaz A; Abbas A; Pawlik TM
Ann Surg Oncol; 2021 Dec; 28(13):8162-8171. PubMed ID: 34036428
[TBL] [Abstract][Full Text] [Related]
12. Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers.
Beatrici E; Paciotti M; Nguyen DD; Filipas DK; Qian Z; Lughezzani G; Daniels D; Lipsitz SR; Kibel AS; Cole AP; Trinh QD
Cancer; 2024 May; ():. PubMed ID: 38798127
[TBL] [Abstract][Full Text] [Related]
13. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.
Deboever N; Correa AM; Feldman H; Mathur U; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Walsh GL; Vaporciyan AA; Antonoff MB; Rajaram R
J Thorac Cardiovasc Surg; 2024 Jan; 167(1):329-337.e4. PubMed ID: 37116780
[TBL] [Abstract][Full Text] [Related]
14. Association of race with receipt of definitive therapy for high risk prostate cancer in older men.
Patel SA; Liu Y; Mahal BA; Jani AB; Sanda MG; Royce TJ; Fischer-Valuck BW
J Geriatr Oncol; 2022 Mar; 13(2):200-206. PubMed ID: 34563484
[TBL] [Abstract][Full Text] [Related]
15. Variation in quality of care among older men with localized prostate cancer.
Jayadevappa R; Chhatre S; Johnson JC; Malkowicz SB
Cancer; 2011 Jun; 117(11):2520-9. PubMed ID: 24048800
[TBL] [Abstract][Full Text] [Related]
16. Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign.
Friedlander DF; von Landenberg N; Löppenberg B; Noldus J; Lipsitz SR; Cole AP; Abdollah F; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
J Urol; 2019 Apr; 201(4):728-734. PubMed ID: 30633112
[TBL] [Abstract][Full Text] [Related]
17. Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals.
Lima HA; Alaimo L; Moazzam Z; Endo Y; Woldesenbet S; Katayama E; Munir MM; Shaikh C; Ruff SM; Dillhoff M; Beane J; Cloyd J; Ejaz A; Resende V; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4363-4372. PubMed ID: 36800128
[TBL] [Abstract][Full Text] [Related]
18. Treatment in Disproportionately Minority Hospitals Is Associated With Increased Risk of Mortality in Sepsis: A National Analysis.
Rush B; Danziger J; Walley KR; Kumar A; Celi LA
Crit Care Med; 2020 Jul; 48(7):962-967. PubMed ID: 32345833
[TBL] [Abstract][Full Text] [Related]
19. Medicare's Hospital Acquired Condition Reduction Program Disproportionately Affects Minority-serving Hospitals: Variation by Race, Socioeconomic Status, and Disproportionate Share Hospital Payment Receipt.
Zogg CK; Thumma JR; Ryan AM; Dimick JB
Ann Surg; 2020 Jun; 271(6):985-993. PubMed ID: 31469746
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data Base.
Amini A; Rusthoven CG; Jones BL; Armstrong H; Raben D; Kavanagh BD
Urol Oncol; 2016 Apr; 34(4):165.e1-9. PubMed ID: 26699831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
